Walk Vascular
- Company typePrivate
- Founded-
- HeadquartersIrvine, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Walk Vascular firmographics
Firmographics- Name
- Walk Vascular
- Website
- https://jeti.tv
- Company type
- Private
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Walk Vascular industry classification
Industry- Product category
- Peripheral Vascular Thrombectomy Devices
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
- akta.pro secondary industry
- Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE)
Keywords
Where Walk Vascular is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Walk Vascular business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Sales: Abbott's Peripheral Vascular division generates revenue through the sale of disposable interventional devices including guide wires, balloon catheters, stents, atherectomy systems, embolic protection devices, and closure systems. These are predominantly single-use devices intended for one-time use only, creating recurring revenue from procedure volume.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B enterprise sales model for healthcare providers |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Walk Vascular product offering
Product offeringCore offering
Walk Vascular is a commercial-stage medical device company that develops a minimally invasive mechanical aspiration thrombectomy system. The company's core product is designed for removing blood clots from peripheral vasculature through mechanical aspiration, addressing conditions such as peripheral artery disease and related thrombotic events. The company operates from Irvine, United States, with a focused product portfolio targeting interventional vascular procedures.
Differentiator
Problem solved
Functional benefit
Products and services
- Minimally Invasive Mechanical Aspiration Thrombectomy System
Quantifiable outcome
- PAD affects over 236 million people worldwide with prevalence in 15-20% of people over 70 years of age
Companies that use Walk Vascular
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
Walk Vascular technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
Walk Vascular partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Cardiovascular Systems Inc. (CSI)coreCardiovascular Systems Inc. (CSI), a subsidiary of Abbott Group of Companies, manufactures the Diamondback 360 Peripheral Orbital Atherectomy System. Abbott distributes this product through its vascular sales channel, providing a comprehensive orbital atherectomy solution as part of its peripheral intervention portfolio.
- Surmodics Inc.coreSurmodics Inc. manufactures the SurVeil Drug-Coated Balloon, which is distributed by Abbott Group of Companies. This partnership provides Abbott with a differentiated paclitaxel-coated balloon technology for peripheral vascular interventions.
Scale indicators2 records
Recent moves3 records
Expansion highlights2 records
Walk Vascular competitors and assessment
Company assessmentBroad incumbents
- Boston Scientific: Boston Scientific has a peripheral intervention portfolio that overlaps with the thrombectomy/peripheral vascular space and competes for hospital vascular procedure budgets.
- BD (Bard Peripheral Vascular): BD's peripheral vascular business includes catheters, guidewires, and intervention devices serving the same hospital vascular procedure accounts Walk Vascular targets.
- Abbott (Peripheral Vascular Division): Abbott offers the JETi All-in-One Peripheral Thrombectomy System as part of its broad peripheral intervention portfolio covering access, preparation, treatment, and closure — competing with Walk Vascular's aspiration thrombectomy system from a position of scale and breadth.
Direct peers
- Inari Medical (Stryker): Inari Medical develops mechanical thrombectomy systems (ClotTriever for DVT, FlowTriever for PE) and is the most direct competitor in the mechanical aspiration thrombectomy space since acquisition by Stryker.
- Penumbra: Penumbra's Indigo Aspiration System is a leading mechanical aspiration thrombectomy platform for peripheral and venous applications, directly comparable to Walk Vascular's minimally invasive aspiration thrombectomy technology.
- AngioDynamics: AngioDynamics markets mechanical thrombectomy and aspiration catheters (including AlphaVac for PE) addressing the same peripheral and venous clot-removal use cases targeted by Walk Vascular.
Emerging players
- Cardio Flow: Cardio Flow is an emerging player developing mechanical thrombectomy technology for peripheral artery applications — directly overlapping with Walk Vascular's aspiration thrombectomy niche.
- Surmodics: Surmodics develops drug-coated balloon and peripheral surface coating technology (including partnership-manufactured devices like SurVeil distributed by Abbott) addressing peripheral vascular disease procedures adjacent to Walk Vascular's space.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Walk Vascular social profiles
Digital presenceWalk Vascular financial estimates
Financial estimateRevenue estimate
Valuation estimate
Walk Vascular leadership team
Management profileNumber of profiles
Profiles1 record
Walk Vascular funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Walk Vascular M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Walk Vascular
What does Walk Vascular do?
Walk Vascular is a commercial-stage medical device company that develops a minimally invasive mechanical aspiration thrombectomy system. The company's core product is designed for removing blood clots from peripheral vasculature through mechanical aspiration, addressing conditions such as peripheral artery disease and related thrombotic events. The company operates from Irvine, United States, with a focused product portfolio targeting interventional vascular procedures.
When was Walk Vascular founded?
Walk Vascular was founded in -1. It employs 1 to 10 people.
Where is Walk Vascular based?
Walk Vascular is headquartered in Irvine, United States, in the North America region.
How does Walk Vascular make money?
One revenue line is on record: medical Device Sales.
Who are Walk Vascular's main competitors?
Broad incumbents on record are Boston Scientific, BD (Bard Peripheral Vascular) and Abbott (Peripheral Vascular Division). Direct peers are Inari Medical (Stryker), Penumbra and AngioDynamics. Emerging players are Cardio Flow and Surmodics.
Does Walk Vascular have an API?
No public API is recorded for Walk Vascular.
What industry is Walk Vascular in?
Walk Vascular's product category is Peripheral Vascular Thrombectomy Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy). Its NAICS code is 3391 and its SIC code is 3841.